Risk of adverse events following the initiation of antihypertensives in older people with complex health needs: a self-controlled case series in the United Kingdom.

"Declaration of Conflicts of Interest D.P.-A. receives funding from the UK National Institute for Health and Care Research (NIHR) in the form of a senior research fellowship and from the Oxford NIHR Biomedical Research Centre. His research group has received funding from the European Medicines Agency and Innovative Medicines Initiative. His research group has received research grant/s from Amgen, Chiesi-Taylor, GSK, Novartis and UCB Biopharma. His department has also received advisory or consultancy fees from Amgen, Astellas, Astra Zeneca, Johnson and Johnson, and UCB Biopharma; and speaker fees from Amgen and UCB Biopharma. Janssen and Synapse Management Partners have supported training programmes organised by D.P.-A.’s department and open for external participants organised by his department outside the submitted work. All other authors declare no conflict. Declaration of Sources of Funding The project was supported by the National Institute for Health and Care Research (NIHR) Oxford Biomedical Research Centre (BRC). D.P.-A. is funded through a NIHR Senior Research Fellowship (grant number SRF-2018-11-ST2-004). The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health and Care Research or the Department of Health."

"Declaration of Sources of Funding The project was supported by the National Institute for Health and Care Research (NIHR) Oxford Biomedical Research Centre (BRC). D.P.-A. is funded through a NIHR Senior Research Fellowship (grant number SRF-2018-11-ST2-004). The views expressed in this publication are those of the authors and not necessarily those of the NHS, the National Institute for Health and Care Research or the Department of Health."